The results demonstrated that high TP73-AS1 expression was not significantly associated with the age or gender of cancer patients (age: OR = 1.082, 95% CI 0.817-1.433; gender: OR = 1.034, 95% CI 0.772-1.385). This evidence concerns the gene TP73 and cancer.